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Abstract
© 2018 Ayrat Usmanovich Ziganshin et al. Background and Objective: Inhibitory action of ATP
on  contractions  of  frog  isolated  sartorius  muscle  was  shown  earlier,  while  hydrocortisol
prevented that effect of ATP. The aim of this study was to investigate whether ATP also inhibits
the contractility of sartorius muscle on stress-induced animals. Materials and Methods: The
influence of ATP on contractions and end-plate current (EPC) of sartorius muscles isolated from
frogs exposed to electric foot-shock stimulation (EFSS) was analyzed. Results: In the muscles of
frogs exposed to EFSS, the inhibitory effect of ATP on contractions was significantly decreased
and on EPC was abolished. The level of cortisol was much higher in the blood obtained from
EFSS animals comparing with control ones. Conclusion: The EFSS has inhibitory action on the
effect of ATP on the frog sartorius muscle and that could be due to increase of cortisol blood
level.
http://dx.doi.org/10.3923/ijp.2018.1198.1202
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